SEPTIC SHOCK - 10/09/11
Résumé |
In 1963, before the advent of critical care medicine, a study of 900 infants at the University of Minnesota reported a 97% mortality rate with gram-negative sepsis and septic shock.34 In 1992, the J-5 antibody and HA-1A endotoxin antibody trial for pediatric sepsis and septic shock reported an approximate 20% to 25% mortality rate for children (Centocor, personal communication, 1993).3 In 1993, a multicenter trial of corticosteroids for pediatric sepsis in three African hospitals showed an approximate 10% mortality rate for children in the experimental and the placebo control groups (American Academy of Pediatrics meeting, critical care section). In 1996, a single institution study of 100 children with sepsis-induced organ failure showed a 15% overall mortality rate.32 Despite these remarkable improvements in outcome, sepsis and septic shock remain an important cause of morbidity and mortality in neonates and children.53, 76, 96
Le texte complet de cet article est disponible en PDF.Plan
| Address reprint requests to Joseph A. Carcillo, MD, Division of Pediatric Critical Care, Children's Hospital of Pittsburgh, 3705 5th Avenue, Pittsburgh, PA 15213 |
Vol 13 - N° 3
P. 553-574 - juillet 1997 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
